Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06586723 · ClinicalTrials.gov registry record · NA

Impact Trial of Helping Educational Leaders Mobilize Evidence

A NA study of Child Development and Child Behavior, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06586723: Recruiting NA study of Child Development and Child Behavior, sponsored by University of Washington.

NCT06586723 is a NA study of Child Development and Child Behavior that is actively recruiting participants, run by University of Washington. The registered enrollment target is 400 participants, below the 1,081-participant average among 32 other Child Development trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06586723, a NA study of Child Development and Child Behavior, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Social, emotional, and behavioral (SEB) problems occur frequently among elementary school students, dramatically impede student outcomes, and have been exacerbated by the COVID-19 pandemic. Evidence based practices exist to address student SEB needs, prevent problems, and ensure academic success. However, the implementation of these programs in schools is frequently incomplete, uneven, and occurs with insufficient fidelity to ensure positive effects for students due to significant implementation barriers across multiple levels. The purpose of this Impact Trial is to test the effectiveness of the Helping Educational Leaders Mobilize Evidence (HELM) implementation strategy in school-wide implementation of a Tier 1 evidence-based practice (EBP) - Positive Behavioral Interventions and Supports (PBIS).

Primary Outcome

The Tiered Fidelity Inventory (TFI) is a 45-item tool used to provide a valid, reliable, and efficient measure of the extent to which school personnel are applying the core features of PBIS. The TFI is a group-assessment completed by a schoolwide system planning team with external facilitation with strong internal consistency. The scoring criteria for each individual item ranges from 0-3 (0=Not Implemented, 1=Partially Implemented, 3=Fully Implemented); higher scores indicate better outcome.

Interventions

  • BEHAVIORAL PBIS
  • OTHER HELM

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-04-01
Est. Completion 2028-08-31
Phase NA
University of Washington

1,048 total trials

What NCT06586723 shows while recruiting

NCT06586723 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,081-participant average among 32 other Child Development trials with a reported enrollment target (63% lower).

The record links to 2 conditions, with Child Development appearing as the primary indexed condition, and to 2 interventions - of which PBIS is the first listed.

NCT06586723 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06586723 about?

NCT06586723 is a clinical study titled "Impact Trial of Helping Educational Leaders Mobilize Evidence". Social, emotional, and behavioral (SEB) problems occur frequently among elementary school students, dramatically impede student outcomes, and have been exacerbated by the COVID-19 pandemic. Evidence based practices exist to address student SEB needs, prevent problems, and ensure academic success. Ho...

What is the current status of trial NCT06586723?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-04-01. Estimated completion is 2028-08-31.

What conditions does trial NCT06586723 study?

This clinical trial studies the following conditions: Child Development, Child Behavior.

What interventions are being tested in trial NCT06586723?

The interventions under investigation include: PBIS (BEHAVIORAL), HELM (OTHER).

Who is sponsoring clinical trial NCT06586723?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06586723 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06586723's enrollment target sits among peer trials

400 11th of 32 higher than 22 of 32 other Child Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Child Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06586723, the US trial registry maintained by the National Library of Medicine. NCT06586723 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.